---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-013446"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:18:32.081448+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences stockholders approve reverse stock split; board sets ratio at 1-for-35

## Summary
- Stockholders approved reverse stock split at Special Meeting on Oct 28, 2024 with 4,241,540 for, 2,792,189 against, 18,228 abstain.
- Board of Directors subsequently approved a ratio of 1-for-35 for the reverse stock split.
- Reverse split ratio may be implemented at board's discretion within one year of meeting date; all other proposed ratios abandoned.

## SEC filing metadata
- accession: 0001654954-24-013446
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495424013446/0001654954-24-013446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495424013446/endra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-013446
- JSON: https://secwatch.observer/filing/0001654954-24-013446.json
- Plain text: https://secwatch.observer/filing/0001654954-24-013446.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.